Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Manno, Daniela ; Ayieko, Philip ; Ishola, David ; Afolabi, Muhammed O. ; Rogers, Baimba ; Baiden, Frank ; Serry-Bangura, Alimamy ; Bah, Osman M. ; Köhn, Brian ; Swaray, Ibrahim ; Owusu-Kyei, Kwabena ; Otieno, Godfrey T. ; Kowuor, Dickens ; Tindanbil, Daniel ; Smout, Elizabeth ; Robinson, Cynthia ; Keshinro, Babajide ; Foster, Julie ; Gallagher, Katherine ; Lowe, Brett ; Douoguih, Macaya ; Leigh, Bailah ; Greenwood, Brian ; Watson-Jones, Deborah
• Description:
  We explored the association of Ebola virus antibody seropositivity and concentration with potential risk factors for infection. Among 1,282 adults and children from a community affected by the 2014-2016 Ebola outbreak in Sierra Leone, 8% were seropositive for virus antibodies but never experienced disease symptoms. Antibody concentration increased with age.
• Subjects:
  Adult Child Disease Outbreaks Ebolavirus Glycoproteins Hemorrhagic Fever, Ebola Humans Immunoglobulin G Seroepidemiologic Studies
• Source:
  Emerg Infect Dis. 2022; 28(3):734-738
• Pubmed ID:
  35202536
• Pubmed Central ID:
  PMC8888237
• Document Type:
  Journal Article
• Place as Subject:
  Sierra Leone
• Volume:
  28
• Issue:
  3
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:f13b68b672c92e78e1b3373c5530beef054ff9abe9209dafea053fd9c853f694
• Download URL:
  https://stacks.cdc.gov/view/cdc/115210/cdc_115210_DS1.pdf
• File Type:
  [PDF - 1.05 MB ]